Breaking
● GLP-1 trial shows 34% reduction in cardiovascular events over 5 years ● Senolytics drug enters Phase III — first human trial results expected Q1 2027 ● FDA fast-tracks CRISPR base-editing therapy for sickle cell disease ● Longevity biotech index up 12% YTD as institutional capital accelerates ● AI diagnostic platform achieves 97.2% accuracy in early-stage pancreatic cancer detection ● Harvard study links CGM use to 23% lower all-cause mortality in non-diabetics
Impact Health Magazine
AI medical diagnostics technology
Technology & Innovation
AI Diagnostics

Machines That See What Doctors Miss

Deep learning models trained on millions of scans are now outperforming radiologists in early detection. Here's what that means for your health.

"The best diagnostic AI doesn't replace the physician — it gives them superhuman pattern recognition at scale."
Dr. Eric Topol, Scripps Research Translational Institute
94.5%

Accuracy of leading AI in early-stage lung cancer detection

40%

Reduction in false positives vs. standard mammography

18 mo

Earlier average detection window with AI-assisted screening

Articles
The Multimodal AI That Reads Your Blood, Genome, and Scan Simultaneously

The Multimodal AI That Reads Your Blood, Genome, and Scan Simultaneously

Foundation models trained on petabytes of clinical data are beginning to synthesize biomarker panels, genomic sequences, and imaging data into a single unified risk score — with implications for preventive medicine that are only beginning to be understood.

Dr. Sarah Chen·Sep 2026·12 min read
Retinal Scans as a Window to Systemic Disease

Retinal Scans as a Window to Systemic Disease

AI analysis of fundus photographs can now predict cardiovascular risk, Alzheimer's onset, and metabolic dysfunction years before symptoms emerge.

Dr. James Okafor·Aug 2026·8 min read
The Democratization Problem: Who Gets Access to AI Diagnostics?

The Democratization Problem: Who Gets Access to AI Diagnostics?

As AI screening tools prove their clinical value, a new equity gap is emerging between those who can afford early detection and those who cannot.

Amara Osei·Aug 2026·7 min read
Dr. Sarah Chen
"We are entering an era where your annual physical will include an AI-generated risk profile that synthesizes more data than any human clinician could process in a lifetime. The question is no longer whether AI can diagnose — it's how we integrate it into care pathways responsibly."
Dr. Sarah Chen
Director of Clinical AI, Stanford Medicine